09637

Dr. Jin Tian, M.D., is Co-Founder since April 2018 and Chief Medical Officer of Alebund Pharmaceuticals (Jiangsu) Limited & serves as its Executive Director from October 2025 and serves as Director since May 20, 2021. He founded Group in April 2018. Dr. Tian also serves as the director of Shanghai Alebund, Alebund HK and Alebund Shanghai. Dr. Tian founded business in April 2018 in Shanghai when Shanghai Alebund was established. He served as a director of Shanghai Alebund since then and also the chairman of the board of Shanghai Alebund since November 2018. In addition, he has also served as an executive director of Alebund Shanghai. Prior to founding Group, Dr. Tian was a seasoned nephrologist with over 30 years of industry experience, including tenures in Abbott and Roche with a focus on clinical development. He previously worked at Abbott Laboratories (now known as Abbvie, Inc), a multinational medical devices and health care company listed on the New York Stock Exchange (stock code: ABT.NYSE). From October 2007 to October 2010, he was the head of clinical science China at Hoffmann-La Roche Inc., a clinical drug development center of Roche Holding AG, a pharmaceutical company listed on the SIX Swiss Exchange (stock code: ROG.SIX) and the OTCQX International Premier market (stock code: RHHBY.OTCQX). Prior to founding business, from October 2010 to December 2015, he successively served as the head of clinical science China and a senior medical director at Roche (China) Holding Ltd., a wholly-owned subsidiary of Roche Holding AG. In addition, Dr. Tian served as an independent clinical study consultant at Vidasym, Inc. from January 2009 to December 2016 and its chief medical officer from January 2017 to April 2018. Dr. Tian obtained a bachelor’s degree in medicine in July 1985 and a master’s degree in nephrology from the Second Military Medical University (now known as Naval Medical University in July 1990. He subsequently received medical and research training in the United States, including studying at UCLA-Harbor Medical Center. He then studied as a resident in internal medicine at the University of Southern California from June 1996 to June 1998, as a resident in internal medicine at the New Jersey Medical School of University of Medicine and Dentistry of New Jersey from July 1998 to June 1999 and held a postdoctoral fellowship in the Department of Internal Medicine (Nephrology) of the School of Medicine of Yale University from July 1999 to June 2002. Dr. Tian was certified by the American Board of Internal Medicine in internal medicine in 1999 and in nephrology in 2001. He is a fellow of the American Society of Nephrology.